Health

MeltMed® Rings in the Holidays with Reduced Pricing and New NAD+ Starter Packs

* Begin your Wellness Journey with Regenerate Starter Packs; * Scientifically formulated to maximise effectiveness of NAD supplement; * Enjoy savings of 50% NEW YORK, Dec. 4, 2023 /PRNewswire/ -- MeltMed ®, an innovative wellness brand revolutionizing the way consumers ...

2023-12-04 15:01 1587

Nona Biosciences Announces Collaboration Agreement with Lycia Therapeutics

CAMBRIDGE, Mass., Dec. 3, 2023 /PRNewswire/ -- Nona Biosciences, a global pioneer of technology innovation and antibody discovery and development solutions, announced today it has entered into a collaboration agreement with Lycia Therapeutics, a leader in extracellular protein degradation.  Lycia...

2023-12-04 13:19 1286

280Bio doses first patient in Phase I clinical trial of TEB-17231, an oral pan-RAS inhibitor in patients with advanced cancers harboring mutations in KRAS, HRAS, or NRAS

SOUTH SAN FRANCISCO, Calif., Dec. 1, 2023 /PRNewswire/ -- 280Bio, Inc., a clinical stage biotechnology company focused on the development of precision oncology medicines, today announced that the first patient was treated with TEB-17231 (YL-17231), a small molecule inhibitor of RAS signaling. 280...

2023-12-01 21:00 1464

So-Young Enters into Strategic Partnership with Healtech to Further Expand Supply Chain Business

BEIJING, Dec. 1, 2023 /PRNewswire/ -- So-Young International Inc. (NASDAQ: SY) ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced that it has entered into a str...

2023-12-01 18:00 2064

GC Biopharma establishes mRNA production facility in Hwasun, Korea

* Completed the construction of a GMP pilot plant in its Hwasun production plant in Jeollanam-do, Korea * Plans to expand its domain from vaccine development to the field of rare disease treatments by proactively securing mRNA platforms YONGIN, South Korea, Dec. 1, 2023 /PRNewswire/ -- GC Bio...

2023-12-01 16:31 1766

Registrational Phase III CLARIFY trial in prostate cancer commences

SYDNEY, Nov. 30, 2023 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for children and adults with cancer, is pleased to announce it has commenced its r...

2023-11-30 22:16 1450

Lunit to Advance Singapore's Healthcare System with AI-powered Solution for Medical Imaging

* Lunit INSIGHT CXR is piloted at Singapore General Hospital and Changi General Hospital through AimSG, a national medical imaging AI platform for Singapore's Public Healthcare SEOUL, South Korea, Nov. 30, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions fo...

2023-11-30 22:10 1925

First patient with metastatic prostate cancer to receive 2 doses of Cu-67 SAR-bisPSMA achieves undetectable PSA level

HIGHLIGHTS * Undetectable levels of Prostate Specific Antigen (PSA) have been reported from the first patient with metastatic castrate-resistant prostate cancer (mCRPC) to ever receive two cycles of Clarity's67Cu-SAR-bisPSMA at the 8GBq dose level. PSA is a marker of tumour burden, clinical re...

2023-11-30 21:59 1606

CABIO unveils NeoHMOs™ series at FIE 2023, targeting growing global demand for infant formula

FRANKFURT, Germany, Nov. 30, 2023 /PRNewswire/ -- Fi Europe & Hi 2023 (FIE 2023), the annual European trade show for natural and healthy food and beverage ingredients, is being held inFrankfurt between November 28 and 30, 2023. Over the past 26 years, cumulative visitor count of the prestigiousFi...

2023-11-30 21:00 1361

The Best Class 4 Laser Therapy Machine Takes Center Stage at The 55th Dusseldorf International Hospital and Medical Equipment Exhibition in 2023

DUSSELDORF, Germany, Nov. 30, 2023 /PRNewswire/ -- Rhein Laser Technologies Ltd., a prominent manufacturer specializing in innovative medical lasers for aesthetic and physiotherapy markets with operations inWuhan and Dusseldorf, has garnered widespread acclaim and attention from industry professi...

2023-11-30 20:40 1325

UroFiber SuperPulsed Thulium Fiber Laser System Officially Debuts at MEDICA 2023

DUSSELDORF, Germany, Nov. 30, 2023 /PRNewswire/ -- UroFiber SuperPulsed Thulium Fiber Laser System , developed by Rhein Laser Technologies Ltd., a pioneer in medical laser technology, made its first appearance at the esteemed MEDICA 2023 inGermany. This groundbreaking s...

2023-11-30 20:30 1163

111, Inc. Announces Third Quarter 2023 Unaudited Financial Results

SHANGHAI, Nov. 30, 2023 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services inChina, today announced its unaudited financial results for the third quart...

2023-11-30 14:00 3965

Clarity's theranostic prostate cancer trial progresses at the highest dose level cohort

HIGHLIGHTS * Cohort 3 of the theranostic SECuRE trial investigating 64Cu/67 Cu-SAR-bisPSMA in metastatic castrate-resistant prostate cancer (mCRPC) has enrolled and treated 3 participants who received therapy with67Cu-SAR-bisPSMA at the highest dose level of 12GBq.­ * No dose limiting toxicit...

2023-11-29 21:58 1519

China Pharma Holdings, Inc. Announced the Completion of Third Party Testing of Dry Eye Disease Therapeutic Device

HAIKOU, China, Nov. 29, 2023 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma", or the "Company"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced that its Dry Eye Disease (DED) therape...

2023-11-29 21:00 3237

Zhang Yu with Tencent Health: AI-Driven Customer Interaction Solution NGES Effectively Supports Pharmaceutical Enterprises' Smart Operations

SHANGHAI, Nov. 29, 2023 /PRNewswire/ -- In recent years, the Chinese pharmaceutical industry has been undergoing significant changes in its operational methods, driven by improvements in national regulations and changes in user behaviors and attitudes. Traditional operational approaches and mark...

2023-11-29 17:49 1962

magAssist Attended 2023 ISMCS to Showcase its Next-Gen Medical Solutions that Improve Treatment Outcomes of Critical Heart Diseases

SUZHOU, China, Nov. 29, 2023 /PRNewswire/ -- Earlier this month, magAssist Co.,Ltd. ("magAssist" and "the Company"), a leading medical developer of extracorporeal life support devices inChina, attended the 29th annual meeting of the International Society for Mechanical Circulatory Support (ISMCS)...

2023-11-29 14:06 1259

PRISM BioLab and Lilly Enter into a Drug Discovery Collaboration on a Protein-Protein Interaction Target

* Collaboration focused on discovering oral inhibitors of protein-protein interaction (PPI) targets by leveraging PRISM BioLab's proprietary PepMetics® technology. * PRISM BioLab receives upfront payments and up to $660 million in total milestones, plus royalties on net sales. TOKYO, Nov. 2...

2023-11-29 04:01 1532

Wonder Tech's Breakthrough in Language Agnostic Voice AI to Bring Scalable Depression Screening to One Billion People Globally

SINGAPORE, Nov. 28, 2023 /PRNewswire/ -- Wonder Technologies PTE. LTD ("Wonder Tech" or "the Company"), a leading AI-driven mental health solutions company based inSingapore, has reached a breakthrough in its acoustics-based AI for depression screening. The AI model, which identifies depression t...

2023-11-29 00:00 1758

Rhino Rescue Expands Horizons at Medica 2023, Exploring New Opportunities in the European Market

DÜSSELDORF, Germany, Nov. 28, 2023 /PRNewswire/ -- Rhino Rescue made a strong appearance at Medica inGermany, showcasing the comprehensive range of its latest technologies and products. During the event, more than 20 companies expressed their intention to partner with Rhino Rescue, thereby expand...

2023-11-28 23:00 1456

Dr. Liu Jian, President of Medicilon Drug Discovery Division, wins the Thomas Alva Edison Patent Award

BOSTON, Nov. 28, 2023 /PRNewswire/ -- Dr. Liu Jian, President of the Drug Discovery Division at Medicilon, has been awarded the Thomas Alva Edison Patent Award for 2023 from the New Jersey Research and Development Committee. This recognition stems from his innovative patent on the PCSK9 inhibitor...

2023-11-28 21:30 1302
1 ... 58596061626364 ... 279